Request Deal Involvement
Bristol-Myers Squibb completed the acquisition of Celgene for $90bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Citigroup
financial advisors
JP Morgan
legal advisors
Wachtell Lipton Rosen & Katz
legal advisors
Slaughter & May
legal advisors
Davies Ward Phillips & Vineberg
commercial advisors
Sodali & Co
legal advisors
Jones Day
legal advisors to financial advisors
Simpson Thacher & Bartlett
pr advisors
Kekst CNC
financial advisors
Evercore
debt providers
Morgan Stanley
financial advisors
Morgan Stanley
legal advisors
Kirkland & Ellis
pr advisors
Sard Verbinnen & Co
legal advisors to financial advisors
Davis Polk & Wardwell
pr advisors
Brunswick Group
debt providers
MUFG Bank
legal advisors
Mayer Brown
pr advisors
Joele Frank
financial advisors
Gordon Dyal & Co
or
Principals
target
CELGENE CORPORATION
bidder
BRISTOL MYERS SQUIBB COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite